These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20980041)

  • 21. Transformations of nanomaterials in the environment.
    Lowry GV; Gregory KB; Apte SC; Lead JR
    Environ Sci Technol; 2012 Jul; 46(13):6893-9. PubMed ID: 22582927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Airborne engineered nanoparticles: potential risks and monitoring challenges for assessing their impacts on children.
    Biskos G; Schmidt-Ott A
    Paediatr Respir Rev; 2012 Jun; 13(2):79-83. PubMed ID: 22475252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of nanoparticles on human and environment: review of toxicity factors, exposures, control strategies, and future prospects.
    Sajid M; Ilyas M; Basheer C; Tariq M; Daud M; Baig N; Shehzad F
    Environ Sci Pollut Res Int; 2015 Mar; 22(6):4122-43. PubMed ID: 25548015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential environmental impact of engineered nanomaterials.
    Colvin VL
    Nat Biotechnol; 2003 Oct; 21(10):1166-70. PubMed ID: 14520401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered nanoparticles in wastewater and wastewater sludge--evidence and impacts.
    Brar SK; Verma M; Tyagi RD; Surampalli RY
    Waste Manag; 2010 Mar; 30(3):504-20. PubMed ID: 19926463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential application of population models in the European ecological risk assessment of chemicals. II. Review of models and their potential to address environmental protection aims.
    Galic N; Hommen U; Baveco JM; van den Brink PJ
    Integr Environ Assess Manag; 2010 Jul; 6(3):338-60. PubMed ID: 20821698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanomaterials and the environment: a review for the biennium 2008-2010.
    Peralta-Videa JR; Zhao L; Lopez-Moreno ML; de la Rosa G; Hong J; Gardea-Torresdey JL
    J Hazard Mater; 2011 Feb; 186(1):1-15. PubMed ID: 21134718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adsorption and inhibition of butyrylcholinesterase by different engineered nanoparticles.
    Wang Z; Zhang K; Zhao J; Liu X; Xing B
    Chemosphere; 2010 Mar; 79(1):86-92. PubMed ID: 20089293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eco-, geno- and human toxicology of bio-active nanoparticles for biomedical applications.
    Robbens J; Vanparys C; Nobels I; Blust R; Van Hoecke K; Janssen C; De Schamphelaere K; Roland K; Blanchard G; Silvestre F; Gillardin V; Kestemont P; Anthonissen R; Toussaint O; Vankoningsloo S; Saout C; Alfaro-Moreno E; Hoet P; Gonzalez L; Dubruel P; Troisfontaines P
    Toxicology; 2010 Mar; 269(2-3):170-81. PubMed ID: 19944128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures.
    Klecka G; Persoon C; Currie R
    Rev Environ Contam Toxicol; 2010; 207():1-93. PubMed ID: 20652664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guest editorial. Environmental fate and effects of nanoparticles.
    Peijnenburg W
    Environ Int; 2011 Aug; 37(6):1043. PubMed ID: 21524796
    [No Abstract]   [Full Text] [Related]  

  • 33. Simulation of chemical metabolism for fate and hazard assessment. II CATALOGIC simulation of abiotic and microbial degradation.
    Dimitrov S; Pavlov T; Dimitrova N; Georgieva D; Nedelcheva D; Kesova A; Vasilev R; Mekenyan O
    SAR QSAR Environ Res; 2011 Oct; 22(7-8):719-55. PubMed ID: 21999837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanopesticides: guiding principles for regulatory evaluation of environmental risks.
    Kookana RS; Boxall AB; Reeves PT; Ashauer R; Beulke S; Chaudhry Q; Cornelis G; Fernandes TF; Gan J; Kah M; Lynch I; Ranville J; Sinclair C; Spurgeon D; Tiede K; Van den Brink PJ
    J Agric Food Chem; 2014 May; 62(19):4227-40. PubMed ID: 24754346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Carbon nanotubes (CNT) and nanoparticles (NP): interaction with lung epithelium and other biological systems].
    Magrini A; Bergamaschi A; Bergamaschi E
    G Ital Med Lav Ergon; 2006; 28(3):266-9. PubMed ID: 17144414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Holistic risk assessment: an emerging process for environmental decisions.
    Harvey T; Mahaffey KR; Velazquez S; Dourson M
    Regul Toxicol Pharmacol; 1995 Oct; 22(2):110-7. PubMed ID: 8577946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental impacts of engineered nanoparticles.
    Shah V
    Environ Toxicol Chem; 2010 Nov; 29(11):2389-90. PubMed ID: 20936691
    [No Abstract]   [Full Text] [Related]  

  • 38. Environmental risk assessment of hydrofluoropolyethers (HFPEs).
    Tsai WT
    J Hazard Mater; 2007 Jan; 139(2):185-92. PubMed ID: 17118547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polybrominated diphenyl ethers: causes for concern and knowledge gaps regarding environmental distribution, fate and toxicity.
    Vonderheide AP; Mueller KE; Meija J; Welsh GL
    Sci Total Environ; 2008 Aug; 400(1-3):425-36. PubMed ID: 18571221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sources and transformations of chlorophenols in the natural environment.
    Czaplicka M
    Sci Total Environ; 2004 Apr; 322(1-3):21-39. PubMed ID: 15081735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.